Successful immunochemotherapy for patients with malignant mesothelioma: Report of two cases

Surgery Today

Volumn 28, Issue 6, 1998, Pages 647-651

  Tani, Masaji ^a   Tanimura, Hiroshi ^a   Yamaue, Hiroki ^a   Mizobata, Shizuma ^a   Yamamoto, Motoki ^a   Iwahashi, Makoto ^a   Ura, Kimiko ^a   Nagai, Yugo ^a   Tsunoda, Takuya ^a   Wakasaki, Hisao ^a   Nanjo, Kishio ^a   Fujino, Kazumi ^a   Yukawa, Susumu ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adoptive immunotherapy; Chemosensitivity test; Cytotoxic T lymphocytes; Malignant mesothelioma; MTT assay; Tumor infiltrating lymphocytes

Indexed keywords

CISPLATIN; DOXORUBICIN;

ADOPTIVE IMMUNOTHERAPY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HUMAN; MALE; MALIGNANT MESOTHELIOMA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COLORIMETRY; COMBINED MODALITY THERAPY; DOXORUBICIN; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; MESOTHELIOMA; MIDDLE AGED; PERITONEAL NEOPLASMS; PROGNOSIS;

EID: 7144251874     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950050200     Document Type: Article

References (25)

1. Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, Lederman G, Corson J (1988) Malignant mesothelioma: prognostic variable in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades. J Clin Oncol 6:147-153
2. Musk AW, Dolin PJ, Armstrong BK, Ford JM, de Klerk NH, Hobbs M (1989) The incidence of malignant mesothelioma in Australia, 1947-1980. Med J Aust 150:242-246
3. Hillerdal G (1983) Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest 77:321-343
4. Ruffle P, Feld R, Cormier Y (1989) Diffuse malignant mesothelioma of pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 7:1157-1168
5. Yamaue H, Tanimura H, Noguchi K, Hotta T, Tani M, Tsunoda T, Iwahashi M, Tamai M, Iwakura S (1992) Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using MTT assay. Br J Cancer 66:794-799
6. Yamaue H, Tanimura H, Nakamori M, Noguchi K, Iwahashi M, Tani M, Murakami K, Ishimoto K (1996) Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay. Dis Colon Rectum 39:416-422
7. Yamaue H, Tanimura H, Noguchi K, Iwahashi M, Tsunoda T, Tani M, Tamai M, Hotta T, Mizobata S, Arii K (1991) Cisplatin treatment renders tumor cells more susceptible to attack by lymphokine-activated killer cells. J Clin Lab Immunol 35:165-170
8. + cytotoxic T lymphocytes stimulated by immobilized anti-CD3 monoclonal antibody and interleukin-2 in cancer patients. Int J Cancer 60:802-807
9. Tani M, Tanimura H, Yamaue H, Iwahashi M, Isunoda T, Tamai M, Noguchi K, Arii K (1992) In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan. Eur J Clin Pharmacol 42:623-628
10. Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Arii K, Noguchi K (1992) The promotive effect of interleukin-4 with interleukin-2 in the proliferation of tumor-infiltrating lymphocytes from patients with malignant tumor. Biotherapy 4:9-15
11. Lerner HJ, Schoenfeld DA, Martin A, Falkson G, Borden E (1983) Malignant mesothelioma. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer 52:1981-1985
12. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
13. Krarup-Hansen A, Hansen HH (1991) Chemotherapy in malignant mesothelioma: a review. Cancer Chemother Pharmacol 28:319-330
14. Aisner J, Wiernik PH (1981) Chemotherapy in the treatment of malignant mesothelioma. Semin Oncol 8:335-343
15. Shin DM, Fossella FV, Umsawasdi T, Murphy WK, Chasen MH, Walsh G, Komaki R, McMurtrey MJ, Hong WK (1995) Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma. Cancer 76:2230-2236
16. Yamaue H, Tanimura H, Iwahashi M, Tani M, Tsunoda T, Tabuse K, Kuribayashi K, Saito K (1989) Role of interleukin-2 and interferon-γ in induction of activated natural killer cells from mice primed in vivo and sequently challenged in vitro with the streptococcal preparation OK432. Cancer Immunol Immunother 29:79-86
17. Tani M, Tanimura H, Yamaue H, Tsunoda T, Iwahashi M, Noguchi K, Tamai M, Hotta T, Mizobata S (1993) Augmentation of lymphokine-activated killer cell activity by lentinan. Anti-cancer Res 13:1773-1776
18. Iwahashi M, Tanimura H, Yamaue H, Tani M, Noguchi K, Mizobata S, Tsunoda T, Tamai M, Hotta T, Arii K, Terasawa H (1994) Ubenimex treatment enhances the susceptibility of gastric cancer cell lines of lymphokine-activated killer cells. Anticancer Res 14:1563-1568
19. Yamaue H, Tanimura H, Tsunoda T, Iwahashi M, Tani M, Tamai M, Inoue M (1990) Functional and phenotypic analyses of interleukin 2-activated tumor-infiltrating lymphocytes. Biotherapy 2:247-259
20. Rosenberg SA, Lotze MT, Yang JC, Aebersold PM, Linehan WM, Seipp CA, White DE (1989) Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg 210:474-485
21. Manning LS, Davis MR, Robinson BWS (1991) Asbestos fibers inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma. Clin Exp Immunol 83:85-91
22. Yanagawa H, Sone S, Fukuta K, Nishioka Y, Ogura T (1991) Local adoptive immunotherapy using lymphokine-activated killer cells and interleukin-2 against malignant pleural mesothelioma: report of two cases. Jpn J Clin Oncol 21:377-383
23. Bowman RV, Manning LS, David MR, Robinson BWS (1991) Chemosensitivity and cytokine sensitivity of maligant mesothelioma. Cancer Chemother Pharmacol 28:420-426
24. Boutin C, Viallat JR, VanZandwijk N, Douillard JT, Paillard JC, Guerin JC, Mignot P, Migueres J, Varlet F, Jehan A, Delepoulle E, Brandely M (1991) Activity of intrapleural recombinant gamma-interferon in malignant mesothelioma. Cancer 67:2033-2037
25. Aoki Y, Takakuwa K, Kodama S, Tanaka K, Takahashi M, Tokunaga A, Takahashi T (1991) Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer. Cancer Res 51:1934-1939